492 related articles for article (PubMed ID: 15315588)
1. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
Riman T; Nilsson S; Persson IR
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
4. Anthropometry and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Ness RB; Allen GO
Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653
[TBL] [Abstract][Full Text] [Related]
5. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
[TBL] [Abstract][Full Text] [Related]
6. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
7. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer.
Wittenberg J; Cook LS; Rossing MA; Weiss NS
Epidemiology; 1999 Nov; 10(6):761-3. PubMed ID: 10535792
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
10. Epidemiologic analysis of breast and gynecologic cancers.
Hulka BS
Prog Clin Biol Res; 1997; 396():17-29. PubMed ID: 9108587
[TBL] [Abstract][Full Text] [Related]
11. Tubal ligation and the risk of ovarian carcinoma.
Cornelison TL; Natarajan N; Piver MS; Mettlin CJ
Cancer Detect Prev; 1997; 21(1):1-6. PubMed ID: 9043756
[TBL] [Abstract][Full Text] [Related]
12. A population-based cohort study of HRT use and breast cancer in southern Sweden.
Olsson H; Bladström A; Ingvar C; Möller TR
Br J Cancer; 2001 Sep; 85(5):674-7. PubMed ID: 11531250
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
[TBL] [Abstract][Full Text] [Related]
14. Estrogen replacement therapy and ovarian cancer.
Folsom AR; Anderson JP; Ross JA
Epidemiology; 2004 Jan; 15(1):100-4. PubMed ID: 14712153
[TBL] [Abstract][Full Text] [Related]
15. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence.
Riman T; Persson I; Nilsson S
Clin Endocrinol (Oxf); 1998 Dec; 49(6):695-707. PubMed ID: 10209555
[TBL] [Abstract][Full Text] [Related]
16. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
[TBL] [Abstract][Full Text] [Related]
18. Reproductive and menstrual risk factors for pancreatic cancer: a population-based study of San Francisco Bay Area women.
Duell EJ; Holly EA
Am J Epidemiol; 2005 Apr; 161(8):741-7. PubMed ID: 15800266
[TBL] [Abstract][Full Text] [Related]
19. Timing of pregnancy and the risk of epithelial ovarian cancer.
Whiteman DC; Siskind V; Purdie DM; Green AC
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):42-6. PubMed ID: 12540502
[TBL] [Abstract][Full Text] [Related]
20. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Allen GO; Ness RB
Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
